Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre (MAHSC), Manchester, UK.
Department of Pharmaceutics, Faculty of Pharmacy, University of Tripoli, Tripoli, Libya.
Diabetes Obes Metab. 2017 Nov;19(11):1537-1545. doi: 10.1111/dom.12964. Epub 2017 Jul 5.
Contemporary data describing type 2 diabetes prevalence, incidence and mortality are limited. We aimed to (1) estimate annual incidence and prevalence rates of type 2 diabetes in the UK between 2004 and 2014, (2) examine relationships between observed rates with age, gender, socio-economic status and geographic region, and (3) assess how temporal changes in incidence and all-cause mortality rates influence changes in prevalence.
Type 2 diabetes patients aged ≥16 years between January 2004 and December 2014 were identified using the Clinical Practice Research Datalink (CPRD). Up to 5 individuals without diabetes were matched to diabetes patients based on age, gender and the general practice. Annual incidence, prevalence and mortality rates were calculated per 10 000 person-years at risk (95% CI). Survival models compared mortality rates in patients with and without type 2 diabetes.
Prevalence rates of type 2 diabetes increased from 3.21% (3.19; 3.22) in 2004 to 5.26% (5.24; 5.29) in 2014. Incidence rates remained stable, overall, throughout the study period. Higher incidence and prevalence rates were related to male gender and deprivation. Individuals with type 2 diabetes were associated with higher risk of mortality (Hazard ratio 1.26 [1.20; 1.32]). Mortality rates declined in patients with and without diabetes throughout the study period. The incidence and prevalence of type 2 diabetes in patients aged 16 to 34 years increased over time.
The rising prevalence of type 2 diabetes in the UK over the last decade is probably explained by patients living longer rather than by increasing incidence of type 2 diabetes.
描述 2 型糖尿病发病率、患病率和死亡率的当代数据有限。我们旨在:(1) 估计 2004 年至 2014 年期间英国 2 型糖尿病的年发病率和患病率;(2) 研究观察到的发病率与年龄、性别、社会经济地位和地理区域之间的关系;(3) 评估发病率和全因死亡率的时间变化如何影响患病率的变化。
使用临床实践研究数据链 (CPRD) 确定 2004 年 1 月至 2014 年 12 月期间年龄≥16 岁的 2 型糖尿病患者。多达 5 名无糖尿病的患者与糖尿病患者按年龄、性别和全科医生进行匹配。每 10000 人-年风险(95%置信区间)计算年发病率、患病率和死亡率。生存模型比较了有和无 2 型糖尿病患者的死亡率。
2004 年 3.19%(3.19;3.22)至 2014 年 5.26%(5.24;5.29),2 型糖尿病的患病率呈上升趋势。总的来说,整个研究期间发病率保持稳定。较高的发病率和患病率与男性性别和贫困有关。患有 2 型糖尿病的人死亡率较高(风险比 1.26[1.20;1.32])。整个研究期间,有和无糖尿病患者的死亡率均下降。16 至 34 岁患者的 2 型糖尿病发病率和患病率随着时间的推移而增加。
过去十年英国 2 型糖尿病患病率上升,可能是由于患者寿命延长,而不是 2 型糖尿病发病率增加所致。